{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:53:38Z","timestamp":1787025218225,"version":"build-2736575974"},"reference-count":50,"publisher":"American Diabetes Association","issue":"11","license":[{"start":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T00:00:00Z","timestamp":1724198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,11,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Diabetic peripheral neuropathy (DPN) affects \u223c50% of the 500 million people with type 2 diabetes worldwide and is considered disabling and irreversible. The current study was undertaken to assess the effect of metformin on peripheral neuropathy outcomes in type 2 diabetes. Participants with type 2 diabetes (n = 69) receiving metformin were recruited and underwent clinical assessment, peripheral nerve ultrasonography, nerve conduction studies, and axonal excitability studies. Also concurrently screened were 318 participants who were not on metformin, and 69 were selected as disease control subjects and matched to the metformin participants for age, sex, diabetes duration, BMI, HbA1c, and use of other diabetes therapies. Medical record data over the previous 20 years were analyzed for previous metformin use. Mean tibial nerve cross-sectional area was lower in the metformin group (metformin 14.1 \u00b1 0.7 mm2, nonmetformin 16.2 \u00b1 0.9 mm2, P = 0.038), accompanied by reduction in neuropathy symptom severity (P = 0.021). Axonal excitability studies demonstrated superior axonal function in the metformin group, and mathematical modeling demonstrated that these improvements were mediated by changes in nodal Na+and K+conductances. Metformin treatment is associated with superior nerve structure and clinical and neurophysiological measures. Treatment with metformin may be neuroprotective in DPN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Article Highlights<\/jats:title>\n                  <\/jats:sec>","DOI":"10.2337\/db24-0365","type":"journal-article","created":{"date-parts":[[2024,8,21]],"date-time":"2024-08-21T19:53:51Z","timestamp":1724270031000},"page":"1875-1882","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":16,"title":["Effect of Metformin on Peripheral Nerve Morphology in Type 2 Diabetes: A Cross-Sectional Observational Study"],"prefix":"10.2337","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7684-0976","authenticated-orcid":false,"given":"Roshan","family":"Dhanapalaratnam","sequence":"first","affiliation":[{"name":"1School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"2Department of Neurology, Prince of Wales Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8323-6048","authenticated-orcid":false,"given":"Tushar","family":"Issar","sequence":"additional","affiliation":[{"name":"1School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiao Leon","family":"Wang","sequence":"additional","affiliation":[{"name":"1School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Tran","sequence":"additional","affiliation":[{"name":"3Department of Endocrinology, Prince of Wales Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"Poynten","sequence":"additional","affiliation":[{"name":"1School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"3Department of Endocrinology, Prince of Wales Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry-Lee","family":"Milner","sequence":"additional","affiliation":[{"name":"1School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"3Department of Endocrinology, Prince of Wales Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie C.G.","family":"Kwai","sequence":"additional","affiliation":[{"name":"4School of Medical, Indigenous and Health Sciences, University of Wollongong, Wollongong, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8883-8825","authenticated-orcid":false,"given":"Arun V.","family":"Krishnan","sequence":"additional","affiliation":[{"name":"1School of Clinical Medicine, University of New South Wales, Sydney, New South Wales, Australia"},{"name":"2Department of Neurology, Prince of Wales Hospital, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2024,8,21]]},"reference":[{"key":"2024102118512453400_B1","volume-title":"IDF Diabetes Atlas.","author":"Magliano","year":"2021","edition":"10th ed"},{"key":"2024102118512453400_B2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"2024102118512453400_B3","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain","volume":"93","author":"Feldman","year":"2017","journal-title":"Neuron"},{"key":"2024102118512453400_B4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"key":"2024102118512453400_B5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"2024102118512453400_B6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"2024102118512453400_B7","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/0026-0495(93)90284-U","article-title":"The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients","volume":"42","author":"Johnson","year":"1993","journal-title":"Metabolism"},{"key":"2024102118512453400_B8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/07853899009147268","article-title":"Contribution of gluconeogenesis to overall glucose output in diabetic and nondiabetic men","volume":"22","author":"Consoli","year":"1990","journal-title":"Ann Med"},{"key":"2024102118512453400_B9","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1210\/jc.2002-021394","article-title":"Metformin rapidly increases insulin receptor activation in human liver and signals preferentially through insulin-receptor substrate-2","volume":"88","author":"Gunton","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2024102118512453400_B10","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/s00125-017-4349-5","article-title":"Metformin and ageing: improving ageing outcomes beyond glycaemic control","volume":"60","author":"Valencia","year":"2017","journal-title":"Diabetologia"},{"key":"2024102118512453400_B11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/14737175.2021.1847645","article-title":"Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system","volume":"21","author":"Demar\u00e9","year":"2021","journal-title":"Expert Rev Neurother"},{"key":"2024102118512453400_B12","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3233\/JAD-180263","article-title":"Metformin use associated with reduced risk of dementia in patients with diabetes: a systematic review and meta-analysis","volume":"65","author":"Campbell","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"2024102118512453400_B13","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1111\/bph.12655","article-title":"Acute metformin preconditioning confers neuroprotection against focal cerebral ischaemia by pre-activation of AMPK-dependent autophagy","volume":"171","author":"Jiang","year":"2014","journal-title":"Br J Pharmacol"},{"key":"2024102118512453400_B14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fnagi.2018.00227","article-title":"Evaluation of metformin on cognitive improvement in patients with non-dementia vascular cognitive impairment and abnormal glucose metabolism","volume":"10","author":"Lin","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"2024102118512453400_B15","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1016\/j.clinph.2018.09.013","article-title":"Indications for neuromuscular ultrasound: expert opinion and review of the literature","volume":"129","author":"Walker","year":"2018","journal-title":"Clin Neurophysiol"},{"key":"2024102118512453400_B16","doi-asserted-by":"crossref","first-page":"20200173","DOI":"10.1259\/bjr.20200173","article-title":"High resolution ultrasonography of peripheral nerves in diabetic patients to evaluate nerve cross sectional area with clinical profile","volume":"94","author":"Narayan","year":"2021","journal-title":"Br J Radiol"},{"key":"2024102118512453400_B17","doi-asserted-by":"crossref","first-page":"110058","DOI":"10.1016\/j.ejrad.2021.110058","article-title":"Ultrasound evaluation of peripheral nerves of the lower limb in diabetic peripheral neuropathy","volume":"145","author":"Goyal","year":"2021","journal-title":"Eur J Radiol"},{"key":"2024102118512453400_B18","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1007\/s00415-021-10485-x","article-title":"Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up","volume":"268","author":"Fionda","year":"2021","journal-title":"J Neurol"},{"key":"2024102118512453400_B19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/mus.27386","article-title":"Nerve ultrasound evaluation of Guillain-Barr\u00e9 syndrome subtypes in northern China","volume":"64","author":"Liu","year":"2021","journal-title":"Muscle Nerve"},{"key":"2024102118512453400_B20","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clinph.2019.07.023","article-title":"Measurement of axonal excitability: consensus guidelines","volume":"131","author":"Kiernan","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"2024102118512453400_B21","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1111\/ene.14805","article-title":"Impact of the metabolic syndrome on peripheral nerve structure and function in type 2 diabetes","volume":"28","author":"Issar","year":"2021","journal-title":"Eur J Neurol"},{"key":"2024102118512453400_B22","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1111\/ene.15534","article-title":"Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes","volume":"29","author":"Dhanapalaratnam","year":"2022","journal-title":"Eur J Neurol"},{"key":"2024102118512453400_B23","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1111\/ene.14850","article-title":"Cross-sectional area reference values for peripheral nerve ultrasound in adults: a systematic review and meta-analysis\u2013Part II: lower extremity nerves","volume":"28","author":"Fisse","year":"2021","journal-title":"Eur J Neurol"},{"key":"2024102118512453400_B24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-5491.2009.02667.x","article-title":"Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy","volume":"26","author":"Bril","year":"2009","journal-title":"Diabet Med"},{"key":"2024102118512453400_B25","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1212\/WNL.53.8.1660","article-title":"Total neuropathy score: validation and reliability study","volume":"53","author":"Cornblath","year":"1999","journal-title":"Neurology"},{"key":"2024102118512453400_B26","volume-title":"Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice.","author":"Kimura","year":"1983"},{"key":"2024102118512453400_B27","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S1388-2457(01)00595-8","article-title":"Excitability of human axons","volume":"112","author":"Burke","year":"2001","journal-title":"Clin Neurophysiol"},{"key":"2024102118512453400_B28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C","article-title":"Threshold tracking techniques in the study of human peripheral nerve","volume":"21","author":"Bostock","year":"1998","journal-title":"Muscle Nerve"},{"key":"2024102118512453400_B29","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.clinph.2013.11.004","article-title":"Axonal excitability in X-linked dominant Charcot Marie Tooth disease","volume":"125","author":"Liang","year":"2014","journal-title":"Clin Neurophysiol"},{"key":"2024102118512453400_B30","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/(SICI)1097-4598(199710)20:10<1296::AID-MUS12>3.0.CO;2-1","article-title":"F-wave latency, the most sensitive nerve conduction parameter in patients with diabetes mellitus","volume":"20","author":"Andersen","year":"1997","journal-title":"Muscle Nerve"},{"key":"2024102118512453400_B31","doi-asserted-by":"crossref","first-page":"1082720","DOI":"10.3389\/fendo.2023.1082720","article-title":"Metformin treatment and risk of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus in Beijing, China","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024102118512453400_B32","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/s41598-021-81631-8","article-title":"The relationship between exacerbated diabetic peripheral neuropathy and metformin treatment in type 2 diabetes mellitus","volume":"11","author":"Hashem","year":"2021","journal-title":"Sci Rep"},{"key":"2024102118512453400_B33","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"2024102118512453400_B34","doi-asserted-by":"crossref","first-page":"105672","DOI":"10.1016\/j.intimp.2019.05.057","article-title":"Preventive role of metformin on peripheral neuropathy induced by diabetes","volume":"74","author":"L\u00f3s","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"2024102118512453400_B35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.ejphar.2015.06.010","article-title":"Metformin attenuates hyperalgesia and allodynia in rats with painful diabetic neuropathy induced by streptozotocin","volume":"764","author":"Ma","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"2024102118512453400_B36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10787-016-0275-2","article-title":"Anti-inflammatory effect of AMPK signaling pathway in rat model of diabetic neuropathy","volume":"24","author":"Hasanvand","year":"2016","journal-title":"Inflammopharmacology"},{"key":"2024102118512453400_B37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2337\/db17-0503","article-title":"Negative regulation of TRPA1 by AMPK in primary sensory neurons as a potential mechanism of painful diabetic neuropathy","volume":"67","author":"Wang","year":"2018","journal-title":"Diabetes"},{"key":"2024102118512453400_B38","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jpain.2022.02.011","article-title":"Activation of 20-HETE synthase triggers oxidative injury and peripheral nerve damage in type 2 diabetic mice","volume":"23","author":"Haddad","year":"2022","journal-title":"J Pain"},{"key":"2024102118512453400_B39","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s00125-013-2991-0","article-title":"Molecular mechanism of action of metformin: old or new insights?","volume":"56","author":"Rena","year":"2013","journal-title":"Diabetologia"},{"key":"2024102118512453400_B40","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/nm.2750","article-title":"Methylglyoxal modification of Nav1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy","volume":"18","author":"Bierhaus","year":"2012","journal-title":"Nat Med"},{"key":"2024102118512453400_B41","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbadis.2015.03.005","article-title":"Metformin and caloric restriction induce an AMPK-dependent restoration of mitochondrial dysfunction in fibroblasts from fibromyalgia patients","volume":"1852","author":"Alcocer-G\u00f3mez","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"2024102118512453400_B42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s004010050764","article-title":"Reactive, degenerative, and proliferative Schwann cell responses in experimental galactose and human diabetic neuropathy","volume":"95","author":"Kalichman","year":"1998","journal-title":"Acta Neuropathol"},{"key":"2024102118512453400_B43","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1210\/en.2013-1097","article-title":"Glucose-induced metabolic memory in Schwann cells: prevention by PPAR agonists","volume":"154","author":"Kim","year":"2013","journal-title":"Endocrinology"},{"key":"2024102118512453400_B44","doi-asserted-by":"crossref","first-page":"37503","DOI":"10.1074\/jbc.M110.136796","article-title":"AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes","volume":"285","author":"Eid","year":"2010","journal-title":"J Biol Chem"},{"key":"2024102118512453400_B45","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/BF01181584","article-title":"Intramembranous particle distribution at the node of Ranvier and adjacent axolemma in myelinated axons of the frog brain","volume":"5","author":"Rosenbluth","year":"1976","journal-title":"J Neurocytol"},{"key":"2024102118512453400_B46","doi-asserted-by":"crossref","first-page":"102348","DOI":"10.1016\/j.npep.2023.102348","article-title":"Metformin promotes Schwann cell remyelination, preserves neural tissue and improves functional recovery after spinal cord injury","volume":"100","author":"Huang","year":"2023","journal-title":"Neuropeptides"},{"key":"2024102118512453400_B47","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s40199-019-00286-z","article-title":"Metformin-induced AMPK activation stimulates remyelination through induction of neurotrophic factors, downregulation of NogoA and recruitment of Olig2+ precursor cells in the cuprizone murine model of multiple sclerosis","volume":"27","author":"Houshmand","year":"2019","journal-title":"Daru"},{"key":"2024102118512453400_B48","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1111\/ene.14805","article-title":"Impact of the metabolic syndrome on peripheral nerve structure and function in type 2 diabetes","volume":"28","author":"Issar","year":"2021","journal-title":"Eur J Neurol"},{"key":"2024102118512453400_B49","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.410210515","article-title":"Reversible and irreversible nodal dysfunction in diabetic neuropathy","volume":"21","author":"Brismar","year":"1987","journal-title":"Ann Neurol"},{"key":"2024102118512453400_B50","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/dme.14085","article-title":"Sonographic assessment of nerve blood flow in diabetic neuropathy","volume":"37","author":"Borire","year":"2020","journal-title":"Diabet Med"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/doi\/10.2337\/db24-0365\/787662\/db240365.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/doi\/10.2337\/db24-0365\/787662\/db240365.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T14:51:57Z","timestamp":1729522317000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/73\/11\/1875\/157146\/Effect-of-Metformin-on-Peripheral-Nerve-Morphology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,21]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,8,21]]},"published-print":{"date-parts":[[2024,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db24-0365","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,21]]}}}